New Perspectives in Rheumatology: May You Live in Interesting Times: Challenges and Opportunities in Lupus Research

Arthritis Rheumatol. 2017 Aug;69(8):1552-1559. doi: 10.1002/art.40109. Epub 2017 Jun 16.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Biomedical Research
  • Calcineurin Inhibitors / therapeutic use
  • Cell- and Tissue-Based Therapy*
  • Clinical Trials as Topic
  • Cytokines / antagonists & inhibitors
  • Histone Deacetylase Inhibitors / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Inflammasomes / antagonists & inhibitors
  • Lupus Erythematosus, Systemic / immunology
  • Lupus Erythematosus, Systemic / therapy*
  • Lymphocyte Depletion
  • Molecular Targeted Therapy
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors
  • Quinolones / therapeutic use
  • Rheumatology

Substances

  • Antibodies, Monoclonal, Humanized
  • Calcineurin Inhibitors
  • Cytokines
  • Histone Deacetylase Inhibitors
  • Immunosuppressive Agents
  • Inflammasomes
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Quinolones
  • epratuzumab
  • belimumab
  • laquinimod